
New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder
Fox News
On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of drugs for schizophrenia in more than 30 years.
This marks the first new class of medications for the brain disorder in several decades, according to a press release. "Schizophrenia is not a one-size-fits-all condition, and people often find themselves in a cycle of discontinuing and switching therapies." Melissa Rudy is senior health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to melissa.rudy@fox.com.
COBENFY is expected to be available in the U.S. in late October, the company noted.
More Related News